Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03505424 · ClinicalTrials.gov registry record · NA
Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03505424: Completed NA study, sponsored by Northwestern University.
NCT03505424 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03505424, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The objective of this study is to determine the extent to which the SMART NICU2HOME (including EMR interface) and the NICU2HOME apps, mobile applications designed for parents of premature infants to receive daily, real-time information about their infants and personalized education material based on parents' anticipated concerns and their infant's clinical status, is effective in: 1) improving parents' competency in caring for their sick infants, 2) reducing stress, 3) supporting parents' social supports and 3) improving NICU outcomes (parent satisfaction, length of stay, readmission rates.)
Primary Outcome
We will use the PSOC Survey for this outcome.
Interventions
- OTHER Group 1: Standard of Care
- OTHER Group 2: NICU2HOME app
- OTHER Group 3: SMART NICU2HOME app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-04-20 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT03505424 record still lists
NCT03505424 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Group 1: Standard of Care is the first listed.
NCT03505424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03505424 about?
NCT03505424 is a clinical study titled "Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge". The objective of this study is to determine the extent to which the SMART NICU2HOME (including EMR interface) and the NICU2HOME apps, mobile applications designed for parents of premature infants to receive daily, real-time information about their infants and personalized education material based on...
What is the current status of trial NCT03505424?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-04-20. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03505424?
The interventions under investigation include: Group 1: Standard of Care (OTHER), Group 2: NICU2HOME app (OTHER), Group 3: SMART NICU2HOME app (OTHER).
Who is sponsoring clinical trial NCT03505424?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03505424's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI